News




This funding opportunity supports projects to adapt, apply, and validate existing or emerging technologies into a new generation of user-friendly, low-cost technologies for preventing, detecting,...

The ITCR program supports research-driven informatics technology development spanning all aspects of cancer research. ITCR supports innovative methods and algorithms, early and advanced stage...

The NCI Cancer Imaging Program fosters advances in in vivo medical imaging sciences through support of basic and applied research in cancer imaging as well as promotion of imaging in clinical...

NCI and Cancer Research UK are partnering for Cancer Grand Challenges to fund large-scale novel ideas by multidisciplinary research teams from around the world in response to nine challenges...

The NIH Common Fund Human Biomolecular Atlas Program (HuBMAP) aims to develop a framework for functional mapping the human body with cellular...

NCI announces 12 new funding opportunities for topics ranging from therapeutics to digital health. Check our "...

New RFA to support Academic-Industrial Partnerships for technologies to capture and quantify tumor associated cells,...

NCI’s Office of Cancer Nanotechnology Research has published a new funding opportunity announcement for the Innovative Research in Cancer Nanotechnology (IRCN) initiative,...

A new funding opportunity (RFA-CA-17-023) has been issued by the NCI to address the...

NCI invites requests for supplemental funding to support new multidisciplinary scientific collaborations among awardees...

In direct response to Vice President Biden’s Cancer Moonshot, Atlanta-based Global Center for Medical Innovation (GCMI) and T3 Labs are collaborating with the...

Tony Dickherber to present IMAT funding opportunities and current portfolio breakdown at BMES 2016 in Minneapolis, MN.

IMAT and ITCR launching a new effort to catalyze collaborations across the two programs. Contact Tony Dickherber for details.

An extensive impact assessment of the IMAT program was recently completed by a professional evaluation firm (Ripple Effect Communications, Inc). NCI is thankful to all investigators that assisted...

Next IMAT Principal Investigators’ meeting to be held on the NIH campus on Dec1-2, 2016. Registration details coming soon.

Review of single molecule nucleic acid analysis using micro- and nano-fluidic platforms in Lab on a Chip

Haplotyping via high-throughput, linked-read sequencing with small input DNA requirements in Nature Biotechnology

Advancing Molecular Ion Beam Imaging platform in Nature Methods.

Duplex sequencing demonstrated in PNAS.

Pages